Patents by Inventor Pei-Qiang Huang

Pei-Qiang Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions related to retinoid receptor-selective pathway
    Patent number: 10087156
    Abstract: Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenviroment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: October 2, 2018
    Assignees: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, XIAMEN UNIVERSITY
    Inventors: Xiao-kun Zhang, Ying Su, Hu Zhou, Wen Liu, Pei-Qiang Huang
  • METHODS AND COMPOSITIONS RELATED TO RETINOID RECEPTOR-SELECTIVE PATHWAY
    Publication number: 20170313668
    Abstract: Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenviroment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.
    Type: Application
    Filed: February 16, 2017
    Publication date: November 2, 2017
    Inventors: Xiao-kun ZHANG, Ying SU, Hu ZHOU, Wen LIU, Pei-Qiang HUANG
  • Methods and compositions related to a retinoid receptor-selective pathway
    Patent number: 9611235
    Abstract: Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenvironment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: April 4, 2017
    Assignees: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE, XIAMEN UNIVERSITY
    Inventors: Xiao-kun Zhang, Ying Su, Hu Zhou, Wen Liu, Pei-Qiang Huang
  • METHODS AND COMPOSITIONS RELATED TO A RETINOID RECEPTOR-SELECTIVE PATHWAY
    Publication number: 20150266842
    Abstract: Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenvironment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.
    Type: Application
    Filed: May 6, 2011
    Publication date: September 24, 2015
    Inventors: Xiao-kun Zhang, Ying Su, Hu Zhou, Wen Liu, Pei-Qiang Huang